Notes and Changes

To register for this event email for login details.

The talk will focus on ways patents and patent licensing are used (and could be used) as governance instruments for human genome editing. Professor Sherkow will provide a brief introduction to the main tool of gene editing, CRISPR/cas9 which has itself been subject to a long running patent dispute. The talk will then proceed to discuss some mechanics and concerns of the patent instrument as a governance tool.